Neogen Chemicals Limited announced that its step-down subsidiary, Neogen Morita New Materials Limited (NML), has approved a preferential issue of equity shares worth ₹76.80 crore to Morita Investment Limited (MIL). The transaction grants MIL a 9.09% stake in the subsidiary.

The Board of Directors of NML approved the issuance of 7,20,000 equity shares at a price of ₹1,066.66 per share on September 26, 2026. This transaction is executed in accordance with the Joint Venture Agreement signed between Neogen Ionics Limited and MIL on August 31, 2025.

Transaction Structure

The preferential allotment involves a single allottee, Morita Investment Limited, which is a wholly owned subsidiary of Morita Chemicals Industries Co. Limited (MCL). The issue price includes a premium of ₹1,056.66 per share over the face value of ₹10.

The transaction remains subject to approval from the members of Neogen Chemicals Limited and other requisite statutory and regulatory clearances. As NML is an unlisted public limited company, SEBI ICDR Regulations lock-in requirements do not apply.

Post-Allotment Holdings

The issuance dilutes the existing holding structure by introducing MIL as a non-promoter public shareholder. Prior to this allotment, MIL held no equity in NML.

Strategic Implications

The entry of Morita Investment Limited marks a significant step in the joint venture between Neogen Ionics Limited and MCL. By acquiring a 9.09% stake in NML, MIL strengthens its operational and financial alignment with the subsidiary. The capital infusion supports the strategic objectives outlined in the August 2025 Joint Venture Agreement.

Neogen Chemicals announced its participation in a virtual analysts and investors group meeting scheduled for Monday, September 28, 2026. The session is set to begin at 4:00 pm (IST) and will be conducted via a group meeting format.

The company filed this intimation with the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Unnati Kanani, Company Secretary & Compliance Officer, on September 23, 2026.

Meeting Details

The upcoming interaction is part of the Arihant Capital – Bharat Connect Conference: Rising Stars. Neogen Chemicals management will discuss the company's business overview, financial performance, and future outlook during the session.

Disclosure Guidelines

The company clarified that no unpublished price sensitive information will be shared during the meeting. Additionally, the date and list of participants remain subject to change due to exigencies involving organizers, investors, analysts, or the company itself.

Investors can access the presentation and further details through the company's official investor relations portal.